In the quest to better understand infant respiratory health, scientists are increasingly turning to advanced techniques that offer greater precision and less invasiveness. One such promising tool is respiratory oscillometry, a method that has gained attention for its potential to transform the landscape of pediatric pulmonary diagnostics. Recently, a comprehensive scoping review by Veneroni, Ramaswamy, Gray, and colleagues, published in Pediatric Research, delves into the use of respiratory oscillometry in infants, shedding light on its current applications, technical foundations, and future prospects.
Respiratory oscillometry stands out because it offers a noninvasive way to assess lung mechanics by measuring the impedance of the respiratory system. This impedance is essentially how much the lungs resist airflow when subjected to pressure oscillations delivered through a mouthpiece. The technique involves superimposing small pressure oscillations during normal tidal breathing, which enables the measurement of respiratory resistance and reactance across different frequencies. For infants, whose compliance and cooperation with complex testing methods are inherently limited, oscillometry presents an ideal approach, circumventing the need for forced maneuvers required in traditional spirometry.
The method provides detailed information on both central and peripheral airway function, which is crucial in detecting early changes in the lung’s mechanical properties. Unlike spirometry, which primarily measures airflow and lung volumes during forced or voluntary maneuvers, oscillometry can capture subtle dysfunctions in the peripheral airways that are otherwise difficult to evaluate. This sensitivity is especially pertinent in infants, who are vulnerable to developmental respiratory diseases such as bronchopulmonary dysplasia (BPD), asthma, and other chronic lung conditions that can begin early in life.
One of the central themes emerging from the review is how respiratory oscillometry could revolutionize clinical practice by enabling earlier detection of respiratory disorders. Early intervention is paramount in improving outcomes for infants with compromised lung health, and oscillometry provides clinicians and researchers a valuable tool for monitoring lung function longitudinally without causing undue stress or discomfort to the child. The authors emphasize that the method’s ability to assess lung mechanics repeatedly with minimal effort at the bedside is a game-changer in pediatric pulmonology.
Technically, oscillometry measurements focus on two main parameters: resistance (R) and reactance (X). Resistance reflects the energy required to move air through the airways, essentially indicating airway obstruction, while reactance relates to the elastic and inertial properties of lung tissue and airways. These parameters can be measured at multiple frequencies, offering a frequency-dependent profile that helps distinguish between central and peripheral airway involvement. This frequency-dependent analysis is vital for detecting heterogeneous disease patterns prevalent in infant airway diseases.
Despite its advantages, the application of respiratory oscillometry in infants faces several challenges. For instance, establishing normative data across different ages and ethnicities remains a critical hurdle. Infant lungs are rapidly developing, with changes in airway size, lung compliance, and lung volumes occurring in the first years of life, all of which could influence oscillometry results. The review underscores the need for extensive population-based studies to generate robust reference values that can reliably differentiate between health and disease.
Another technical consideration is the choice of oscillometric devices and protocols. Various commercial devices with differing technologies, such as impulse oscillometry versus forced oscillation techniques, produce data that may not be directly comparable. Standardization efforts, therefore, are necessary to harmonize procedures for measurement and interpretation, ensuring consistent and reproducible results. This would help accelerate the integration of oscillometry into routine clinical settings and multi-center research collaborations.
Further, the authors point out how the use of oscillometry complements other respiratory function tests and imaging modalities. While lung function tests quantify mechanical impairment, imaging techniques visualize structural changes. Bridging these diagnostic approaches could enhance the phenotyping of respiratory diseases in infants, facilitating personalized treatment plans that target specific pathophysiological mechanisms, such as inflammation, airway remodeling, or fibrosis.
Importantly, the review highlights the emerging role of oscillometry in monitoring therapeutic responses. Infants undergoing treatment for conditions like bronchiolitis or early asthma could benefit from oscillometry-based lung function tracking, allowing clinicians to evaluate treatment efficacy objectively and tailor interventions accordingly. This dynamic monitoring capability aligns well with the principles of precision medicine and could reduce unnecessary medication exposure by identifying responders and non-responders early in the treatment course.
The portability and ease of use of oscillometric devices also position them well for use in low-resource settings or during home visits, expanding access to lung function assessment beyond tertiary care centers. This accessibility could accelerate early diagnosis and prompt intervention in underserved populations, potentially reducing respiratory morbidity and mortality globally.
Future research avenues involve refining the technology further to improve sensitivity and specificity for detecting subtle lung function abnormalities. Integration with artificial intelligence and machine learning algorithms could enable automated interpretation of oscillometric data, facilitating quicker clinical decisions and large-scale epidemiological studies. Moreover, combining oscillometry with biomarker assessments from non-invasive sources like exhaled breath condensate might provide deeper insights into disease mechanisms.
Veneroni and colleagues’ scoping review ultimately portrays respiratory oscillometry as a versatile, infant-friendly lung function test with the potential to revolutionize pediatric respiratory medicine. They advocate for concerted efforts to overcome current limitations through methodological standardization, longitudinal cohort studies, and technological advancements. The promise of oscillometry lies in its ability to detect early lung disease, guide therapy, and monitor disease progression with minimal discomfort and maximal clinical impact.
As respiratory diseases in infancy continue to be a major cause of morbidity globally, innovations like oscillometry are crucial for shifting paradigms toward more proactive and personalized care. This review captures the growing enthusiasm in the scientific community for exploiting oscillometry’s unique capabilities to improve infant health trajectories and, ultimately, lifelong respiratory outcomes.
By providing clinicians, researchers, and policymakers with a clear roadmap, this comprehensive review sparks a new wave of research and clinical application around respiratory oscillometry. The future of infant lung health diagnosis and management could very well hinge on this elegant technique, promising a future where fragile and vulnerable patients can breathe easier with timely and precise respiratory assessments.
Subject of Research: Respiratory oscillometry applications in infant pulmonary function assessment
Article Title: Use of respiratory oscillometry in infants: a scoping review
Article References:
Veneroni, C., Ramaswamy, V.V., Gray, D.M., et al. Use of respiratory oscillometry in infants: a scoping review. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-05014-3
Image Credits: AI Generated
DOI: 06 May 2026
